MEDINET
Home Site Map Japanese
Corporate Information About Immuno-Cell Therapy Research and Development Press Release IR Information Inquiaries
Home　≫　Site Map
　
　
Home
　│
　│　-----------------------------------------------------------------
　│
　│　【Company Information】
　├─┬Philosophy
　│　├Message from the Management
　│　├Charter of Corporate Activity
　│　├Corporate Profile
　│　├Offices/Laboratory/CPCs
　│　└History
　│
　│　-----------------------------------------------------------------
　│
　│　【About Immuno-Cell Therapy】
　├──Immuno-Cell Therapy Total Support Service
　│　　　├About Immuno-Cell Therapy
　│　　　├Immuno-Cell Therapies
　│　　　├Business Model
　│　　　├Types of Services
　│　　　├Further Service Development
　│　　　├Safety and Quality Control
　│　　　├ISO 9001 Qualified Service
　│　　　├Introduction of Cell Processing Center
　│　　　└[Video]Immuuo-cell: Cytotoxicity towards Cancer Cell
　│
　│　-----------------------------------------------------------------
　│
　│　【Research and Development】
　├─┬Research Philosophy
　│　├Academic Activities
　│　├Formation for Effective Research and Development
　│　│　├Plan and Control for Research and Development
　│　│　├Fundamental Research
　│　│　├Technological Development
　│　│　└Clinical Development
　│　└Intetectual Property Strategy
　│
　│　-----------------------------------------------------------------
　│
　│　【Press Release】
　├──Press Release
　│
　│　-----------------------------------------------------------------
　│
　│　【IR Information】
　├─┬To Our Shareholders
　│　├Financial Summary
 　│　├IR Data
　│　│　├IR News
　│　│　└Financial Report
　│　└Stock Price Information (Go to Bloomberg's Website)
　│
　│　-----------------------------------------------------------------
　│
　├──【Inquiries】
　│
　│　-----------------------------------------------------------------
　│
　│　【Etc】
　└─┬Terms of Use
　　　├Privacy Policy
　　　└Site Map
　
　
　 　 　 　
　 　 　
Return to Top
　
MEDINET Co., Ltd.